IMAGE: Lung squamous cell carcinoma

Breaking News

Key: Meeting M      Journal J      Funder F

Showing releases 1176-1200 out of 1213.

<< < 43 | 44 | 45 | 46 | 47 | 48 | 49 > >>

Public Release: 6-Aug-2014
Cancer Epidemiology, Biomarkers & Prevention
Study: Many cancer survivors smoke years after diagnosis
Nearly one in 10 cancer survivors reports smoking many years after a diagnosis, according to a new study.
American Cancer Society

Contact: David Sampson
American Cancer Society

Public Release: 5-Aug-2014
Canadian Medical Association Journal
No apparent link between sleep apnea and cancer: Large study
There appears to be no link between obstructive sleep apnea and cancer development, according to a large study published in CMAJ. Several previous studies have shown an association, although they have been small and contain measurement biases.

Contact: Deborah Creatura
Canadian Medical Association Journal

Public Release: 5-Aug-2014
Mammography benefits women over 75
Mammography-detected breast cancer is associated with a shift to earlier stage diagnosis in older women, subsequently reducing the rate of more advanced, difficult-to-treat cases, according to a new study. Researchers said the findings lend support to regular mammography screening in women ages 75 and older.
Kaplan Cancer Research Fund

Contact: Linda Brooks
Radiological Society of North America

Public Release: 5-Aug-2014
Annals of Oncology
Aspirin: Scientists believe cancer prevention benefits outweigh harms
New research from Queen Mary University of London reveals taking aspirin can significantly reduce the risk of developing -- and dying from -- the major cancers of the digestive tract, i.e. bowel, stomach and esophageal cancer.

Contact: Charli Scouller
Queen Mary, University of London

Public Release: 5-Aug-2014
Review of Scientific Instruments
3-in-1 optical skin cancer probe
Researchers from the University of Texas at Austin's Cockrell School of Engineering have now developed a probe that combines into one device three unique ways of using light to measure the properties of skin tissue and detect cancer. The researchers have begun testing their 3-in-1 device in pilot clinical trials and are partnering with funding agencies and start-up companies to help bring the device to dermatologists' offices.

Contact: Jason Socrates Bardi
American Institute of Physics

Public Release: 5-Aug-2014
Genetic testing of tumor is recommended for colorectal cancer patients
Of the 143,000 patients diagnosed with colorectal cancer annually in the US, up to 25 percent have a familial risk of colorectal cancer. A new guideline from the US Multi-Society Task Force on Colorectal Cancer recommends genetic testing of tumors for all newly diagnosed colorectal cancer patients.

Contact: Aimee Frank
American Gastroenterological Association

Public Release: 5-Aug-2014
Nucleic Acids Research
'Treatments waiting to be discovered' inside new database
A University of Colorado Cancer Center study recently published in the top-ranked journal Nucleic Acids Research describes a database named multiMiR, the most comprehensive database collecting information about microRNAs and their targets.
National Institutes of Health, NIH/National Cancer Institute

Contact: Garth Sundem
University of Colorado Denver

Public Release: 5-Aug-2014
American Journal of Respiratory and Critical Care Medicine
Cancer fighter can help battle pneumonia
The tip of an immune molecule known for its skill at fighting cancer may also help patients survive pneumonia, scientists report.
National Institutes of Health

Contact: Toni Baker
Medical College of Georgia at Georgia Regents University

Public Release: 5-Aug-2014
Electronic cigarettes: Many questions, limited research
Electronic cigarettes are booming in popularity -- but there's still only limited evidence on their potential health risks, or their advertised benefits in helping people to quit smoking, according to a research review in the July/August Journal of Addiction Medicine, the official journal of the American Society of Addiction Medicine. The journal is published by Lippincott Williams & Wilkins, a part of Wolters Kluwer Health.

Contact: Connie Hughes
Wolters Kluwer Health

Public Release: 4-Aug-2014
Cancer Research
Weakness of leukemic stem cells discovered
Only one out of every two adult patients survive acute myeloid leukemia. But maybe there is some hope to have a therapy in the future: A team of Frankfurt-based researchers found out that leukemic stem cells have a weakness.

Contact: Anke Sauter
Goethe University Frankfurt

Public Release: 4-Aug-2014
Journal of Thoracic Oncology
Lung cancer diagnosis tool shown to be safe and effective for older patients
Researchers at University Hospital of South Manchester NHS Foundation Trust and The University of Manchester -- part of the Manchester Cancer Research Centre -- have looked at a newer technique: endobronchial ultrasound-guided transbronchial needle aspiration.

Contact: Alison Barbuti
University of Manchester

Public Release: 4-Aug-2014
Annals of Internal Medicine
Screening and drug therapy predicted to make hepatitis C a rare disease
Newly implemented screening guidelines and highly effective drug therapies could make hepatitis C a rare disease in the United States by 2036, according to the results of a predictive model developed at the University of Pittsburgh Graduate School of Public Health. The results of the analysis, funded by the National Institutes of Health and performed with the University of Texas MD Anderson Cancer Center, will be published in the Annals of Internal Medicine.
National Institutes of Health

Contact: Allison Hydzik
University of Pittsburgh Schools of the Health Sciences

Public Release: 4-Aug-2014
Nature Cell Biology
Protein ZEB1 promotes breast tumor resistance to radiation therapy
One protein with the even more out-there name of zinc finger E-box binding homeobox 1, is now thought to keep breast cancer cells from being successfully treated with radiation therapy, according to a study at The University of Texas MD Anderson Cancer Center in Houston.
National Institutes of Health, Cancer Prevention Research Institute of Texas

Contact: Ron Gilmore
University of Texas M. D. Anderson Cancer Center

Public Release: 4-Aug-2014
Cancer Prevention Research
Eating resistant starch may help reduce red meat-related colorectal cancer risk
Consumption of a type of starch that acts like fiber may help reduce colorectal cancer risk associated with a high red meat diet, according to a study published in Cancer Prevention Research, a journal of the American Association for Cancer Research.
National Health and Medical Research Council of Australia, Commonwealth Scientific and Industrial Research Organization, Flinders Medical Center Foundation

Contact: Jeremy Moore
American Association for Cancer Research

Public Release: 4-Aug-2014
BMC Cell Biology
Cell plasticity may provide clues to origin of aggressive type of breast cancer
Healthy breast cells may be able to reinvent themselves -- some have the flexibility to change after they are mature -- which leads researchers to postulate that similarities exist between this occurrence and the origins of a particularly aggressive type of breast cancer.
Susan G. Komen for the Cure, The Breast Cancer Research Foundation, Oracle Giving, Indiana University Melvin and Bren Simon Cancer Center, Indiana University Department of Surgery

Contact: Mary Hardin
Indiana University

Public Release: 4-Aug-2014
Journal of Men's Health
New recommendations for post-treatment care of prostate cancer survivors
Updated guidelines for prostate cancer survivorship care have been published in Journal of Men's Health.

Contact: Kathryn Ryan
Mary Ann Liebert, Inc./Genetic Engineering News

Public Release: 4-Aug-2014
International Journal of Radiation Oncology • Biology • Physics
Single-fraction RT as effective as multiple-fraction RT for palliation of bone metastases
Standardizing prescribing practices for single-fraction radiation therapy for palliation of bone metastases could lead to cost savings and improvement in patients' quality of life, according to a study published in the Aug. 1, 2014, edition of the International Journal of Radiation Oncology ● Biology ● Physics, the official scientific journal of the American Society for Radiation Oncology.

Contact: Michelle Kirkwood
American Society for Radiation Oncology

Public Release: 4-Aug-2014
Triple therapy revs up immune system against common brain tumor
A triple therapy for glioblastoma, including two types of immunotherapy and targeted radiation, has significantly prolonged the survival of mice with these brain cancers, according to a new report by scientists at the Johns Hopkins Kimmel Cancer Center.
WW Smith Charitable Foundation

Contact: Vanessa Wasta
Johns Hopkins Medicine

Public Release: 4-Aug-2014
Version 2.0 of Prostate Cancer Risk Calculator now online, complete with emojis
A calculator to help men and their doctors assess their risk of prostate cancer has had a major upgrade, described online Monday in the Journal of the American Medical Association. 'The current version gives a more nuanced result that helps understand a man's risk of prostate cancer,' said Ian M. Thompson Jr., M.D., director of the Cancer Therapy & Research Center at the UT Health Science Center, who helped develop the risk calculator.
NIH/National Cancer Institute

Contact: Elizabeth Allen
University of Texas Health Science Center at San Antonio

Public Release: 4-Aug-2014
Journal of Clinical Oncology
Patient navigation may aid in breast cancer treatment in high-risk populations
Patient navigation, or the linking of a newly diagnosed cancer patient with a professional trained in assisting patients though the complex journey of cancer diagnosis and treatment, may lead to better breast cancer care in high risk and minority women.

Contact: Gina DiGravio
Boston University Medical Center

Public Release: 3-Aug-2014
New trick for 'old' drug brings hope for pancreatic cancer patients
Scientists have found a new use for an old drug by showing that it shrinks a particular type of pancreatic cancer tumor and stops it spreading.
Cancer Research UK

Contact: Flora Malein
Cancer Research UK

Public Release: 3-Aug-2014
Knowing what to keep and what to trash: How an enzyme distinguishes cellular messages
In the cell, proteins read through messages to distinguish what needs to be saved and what needs to be discarded. Messages that are marked for disposal can drastically alter the fate of a cell. Stem cells use this mechanism to maintain their identity. How does a protein detect the difference between two similar messages? A team of CSHL scientists have found that the protein Dis3l2 uses numerous recognition sites to capture messages for decay.
Watson School of Biological Sciences, Louis Morin Charitable Trust, Robertson Research Fund of Cold Spring Harbor Laboratory

Contact: Jaclyn Jansen
Cold Spring Harbor Laboratory

Public Release: 3-Aug-2014
Nature Genetics
Study finds new genetic risk markers in pancreatic cancer
A large DNA analysis of people with and without pancreatic cancer has identified several new genetic markers that signal increased risk of developing the highly lethal disease, report scientists from Dana-Farber Cancer Institute.
NIH/National Cancer Institute, Lustgarten Foundation

Contact: Anne Doerr
Dana-Farber Cancer Institute

Public Release: 3-Aug-2014
Nature Methods
UMD researchers develop tool to better visualize, analyze human genomic data
Scientists at the University of Maryland have developed a new, web-based tool that enables researchers to quickly and easily visualize and compare large amounts of genomic information resulting from high-throughput sequencing experiments. The free tool, called Epiviz, offers a major advantage over browsers currently available: Epiviz seamlessly integrates with the open-source Bioconductor analysis software widely used by genomic scientists, through its Epivizr Bioconductor package.
National Institutes of Health

Contact: Abby Robinson
University of Maryland

Public Release: 3-Aug-2014
Nature Chemistry
Self-assembling anti-cancer molecules created in minutes
Researchers have developed a simple and versatile method for making artificial anti-cancer molecules that mimic the properties of one of the body's natural defense systems. The chemists, led by professor Peter Scott at the University of Warwick, UK, have been able to produce molecules that have a similar structure to peptides which are naturally produced in the body to fight cancer and infection.
Engineering and Physical Sciences Research Council, University of Warwick

Contact: Tom Frew
University of Warwick

Showing releases 1176-1200 out of 1213.

<< < 43 | 44 | 45 | 46 | 47 | 48 | 49 > >>

  Search News Releases